Cargando…

Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats

BACKGROUND: Cisplatin (CP) is commonly used in the treatment of different types of cancer but nephrotoxicity has been a major limiting factor. Therefore, the present study aimed to study the possible protective effect of rutin against nephrotoxicity induced by cisplatin in rats. METHODS: Forty male...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhoshani, Ali R., Hafez, Mohamed M., Husain, Sufia, Al-sheikh, Abdel Malek, Alotaibi, Moureq R., Al Rejaie, Salim S., Alshammari, Musaad A., Almutairi, Mashal M., Al-Shabanah, Othman A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472980/
https://www.ncbi.nlm.nih.gov/pubmed/28619064
http://dx.doi.org/10.1186/s12882-017-0601-y
_version_ 1783244221614915584
author Alhoshani, Ali R.
Hafez, Mohamed M.
Husain, Sufia
Al-sheikh, Abdel Malek
Alotaibi, Moureq R.
Al Rejaie, Salim S.
Alshammari, Musaad A.
Almutairi, Mashal M.
Al-Shabanah, Othman A.
author_facet Alhoshani, Ali R.
Hafez, Mohamed M.
Husain, Sufia
Al-sheikh, Abdel Malek
Alotaibi, Moureq R.
Al Rejaie, Salim S.
Alshammari, Musaad A.
Almutairi, Mashal M.
Al-Shabanah, Othman A.
author_sort Alhoshani, Ali R.
collection PubMed
description BACKGROUND: Cisplatin (CP) is commonly used in the treatment of different types of cancer but nephrotoxicity has been a major limiting factor. Therefore, the present study aimed to study the possible protective effect of rutin against nephrotoxicity induced by cisplatin in rats. METHODS: Forty male Wistar albino rats were randomly divided into 4 groups. Rats of group 1 control group intraperitoneal (i.p.) received 2.5 ml/kg, group 2 CP group received single dose 5 mg/kg cisplatin i.p. group 3 rutin group orally received 30 mg/kg rutin group 4 (CP plus rutin) received CP and rutin as in group 2 and 3. Kidneys were harvested for histopathology and for the study the gene expression of c-Jun N-terminal kinases (JNK), Mitogen-activated protein kinase 4 (MKK4), MKK7, P38 mitogen-activated protein kinases (P38), tumor necrosis factors alpha (TNF-α), TNF Receptor-Associated Factor 2 (TRAF2), and interleukin-1 alpha (IL-1-α). RESULTS: The cisplatin single dose administration to rats induced nephrotoxicity associated with a significant increase in blood urea nitrogen (BUN) and serum creatinine and significantly increase Malondialdehyde (MDA) in kidney tissues by 230 ± 5.5 nmol/g compared to control group. The animal treated with cisplatin showed a significant increase in the expression levels of the IL-1α (260%), TRFA2 (491%), P38 (410%), MKK4 (263%), MKK7 (412%), JNK (680%) and TNF-α (300%) genes compared to control group. Additionally, histopathological examination showed that cisplatin-induced interstitial congestion, focal mononuclear cell inflammatory, cell infiltrate, acute tubular injury with reactive atypia and apoptotic cells. Rutin administration attenuated cisplatin-induced alteration in gene expression and structural and functional changes in the kidney. Additionally, histopathological examination of kidney tissues confirmed gene expression data. CONCLUSION: The present study suggested that the anti-oxidant and anti-inflammatory effect of rutin may prevent CP-induced nephrotoxicity via decreasing the oxidative stress, inhibiting the interconnected ROS/JNK/TNF/P38 MAPK signaling pathways, and repairing the histopathological changes against cisplatin administration.
format Online
Article
Text
id pubmed-5472980
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54729802017-06-21 Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats Alhoshani, Ali R. Hafez, Mohamed M. Husain, Sufia Al-sheikh, Abdel Malek Alotaibi, Moureq R. Al Rejaie, Salim S. Alshammari, Musaad A. Almutairi, Mashal M. Al-Shabanah, Othman A. BMC Nephrol Research Article BACKGROUND: Cisplatin (CP) is commonly used in the treatment of different types of cancer but nephrotoxicity has been a major limiting factor. Therefore, the present study aimed to study the possible protective effect of rutin against nephrotoxicity induced by cisplatin in rats. METHODS: Forty male Wistar albino rats were randomly divided into 4 groups. Rats of group 1 control group intraperitoneal (i.p.) received 2.5 ml/kg, group 2 CP group received single dose 5 mg/kg cisplatin i.p. group 3 rutin group orally received 30 mg/kg rutin group 4 (CP plus rutin) received CP and rutin as in group 2 and 3. Kidneys were harvested for histopathology and for the study the gene expression of c-Jun N-terminal kinases (JNK), Mitogen-activated protein kinase 4 (MKK4), MKK7, P38 mitogen-activated protein kinases (P38), tumor necrosis factors alpha (TNF-α), TNF Receptor-Associated Factor 2 (TRAF2), and interleukin-1 alpha (IL-1-α). RESULTS: The cisplatin single dose administration to rats induced nephrotoxicity associated with a significant increase in blood urea nitrogen (BUN) and serum creatinine and significantly increase Malondialdehyde (MDA) in kidney tissues by 230 ± 5.5 nmol/g compared to control group. The animal treated with cisplatin showed a significant increase in the expression levels of the IL-1α (260%), TRFA2 (491%), P38 (410%), MKK4 (263%), MKK7 (412%), JNK (680%) and TNF-α (300%) genes compared to control group. Additionally, histopathological examination showed that cisplatin-induced interstitial congestion, focal mononuclear cell inflammatory, cell infiltrate, acute tubular injury with reactive atypia and apoptotic cells. Rutin administration attenuated cisplatin-induced alteration in gene expression and structural and functional changes in the kidney. Additionally, histopathological examination of kidney tissues confirmed gene expression data. CONCLUSION: The present study suggested that the anti-oxidant and anti-inflammatory effect of rutin may prevent CP-induced nephrotoxicity via decreasing the oxidative stress, inhibiting the interconnected ROS/JNK/TNF/P38 MAPK signaling pathways, and repairing the histopathological changes against cisplatin administration. BioMed Central 2017-06-15 /pmc/articles/PMC5472980/ /pubmed/28619064 http://dx.doi.org/10.1186/s12882-017-0601-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Alhoshani, Ali R.
Hafez, Mohamed M.
Husain, Sufia
Al-sheikh, Abdel Malek
Alotaibi, Moureq R.
Al Rejaie, Salim S.
Alshammari, Musaad A.
Almutairi, Mashal M.
Al-Shabanah, Othman A.
Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats
title Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats
title_full Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats
title_fullStr Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats
title_full_unstemmed Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats
title_short Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats
title_sort protective effect of rutin supplementation against cisplatin-induced nephrotoxicity in rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472980/
https://www.ncbi.nlm.nih.gov/pubmed/28619064
http://dx.doi.org/10.1186/s12882-017-0601-y
work_keys_str_mv AT alhoshanialir protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats
AT hafezmohamedm protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats
AT husainsufia protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats
AT alsheikhabdelmalek protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats
AT alotaibimoureqr protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats
AT alrejaiesalims protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats
AT alshammarimusaada protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats
AT almutairimashalm protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats
AT alshabanahothmana protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats